Columbia's drug and materials development software provider Schrödinger has capped a successful initial public offering at more than $232m.
Schrödinger, the US-based life sciences platform developer spun out of Columbia University, closed its initial public offering at more than $232m yesterday.
The company floated last week, issuing nearly 11.9 million shares on the Nasdaq Global Market priced at $17.00 each. Its shares closed at $28.64 on their first day of trading and are at $28.61 at time of publication.
Underwriters Morgan Stanley, BofA Securities, Jefferies and BMO Capital Markets Corp subsequently took up the full over-allotment…